Truist Financial
IONS icon

Truist Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Truist Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$965K Buy
12,846
+187
+1% +$14.8K ﹤0.01% 1728
2025
Q4 		$1M Buy
12,659
+7,847
+163% +$591K ﹤0.01% 1664
2025
Q3 		$315K Buy
+4,812
New +$235K ﹤0.01% 2281
2025
Q1 		– Sell
-6,847
Closed -$239K – 2595
2024
Q4 		$239K Sell
6,847
-501
-7% -$18.7K ﹤0.01% 2285
2024
Q3 		$294K Sell
7,348
-655
-8% -$30.5K ﹤0.01% 2138
2024
Q2 		$381K Sell
8,003
-1,496
-16% -$61.4K ﹤0.01% 2140
2024
Q1 		$412K Sell
9,499
-466
-5% -$22.2K ﹤0.01% 2102
2023
Q4 		$504K Buy
+9,965
New +$477K ﹤0.01% 1963
2022
Q4 		– Sell
-6,420
Closed -$284K – 2635
2022
Q3 		$284K Sell
6,420
-15,944
-71% -$672K ﹤0.01% 2114
2022
Q2 		$828K Sell
22,364
-8,906
-28% -$336K ﹤0.01% 1643
2022
Q1 		$1.16M Buy
31,270
+333
+1% +$10.9K ﹤0.01% 1557
2021
Q4 		$941K Sell
30,937
-40
-0.1% -$1.26K ﹤0.01% 1666
2021
Q3 		$1.04M Buy
30,977
+5,876
+23% +$221K ﹤0.01% 1579
2021
Q2 		$1M Buy
25,101
+3,437
+16% +$135K ﹤0.01% 1651
2021
Q1 		$974K Buy
21,664
+10,408
+92% +$580K ﹤0.01% 1614
2020
Q4 		$636K Sell
11,256
-207
-2% -$10.3K ﹤0.01% 1738
2020
Q3 		$545K Sell
11,463
-392
-3% -$21.8K ﹤0.01% 1685
2020
Q2 		$698K Buy
11,855
+183
+2% +$10.2K ﹤0.01% 1446
2020
Q1 		$551K Sell
11,672
-1,609
-12% -$89.7K ﹤0.01% 1516
2019
Q4 		$802K Buy
+13,281
New +$791K ﹤0.01% 1559

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Truist Financial's IONS Position: Q1 2026 in Review

Truist Financial increased its Ionis Pharmaceuticals (IONS) stake by 1.5% in Q1 2026, buying an estimated $14.8K and bringing the position to 12,846 shares worth $965K. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

Truist Financial first reported a position in IONS in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.16M in Q1 2022. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Truist Financial held 12,846 shares of Ionis Pharmaceuticals worth $965K as of Q1 2026.
  • Truist Financial bought 187 Ionis Pharmaceuticals shares in Q1 2026, an estimated $14.8K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q1 2026, its #1728 holding.
  • Truist Financial first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 20 quarters since.
  • Truist Financial's Ionis Pharmaceuticals position peaked at $1.16M in Q1 2022.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.